Home › Funds › Patient Capital Management, LLC › CROX
Patient Capital Management, LLC position in CROX
CROCS INC · Consumer Discretionary
Patient Capital Management, LLC reported holding 730,946 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$85.7M, representing 2.90% of its reported portfolio and ranking #16 among its reported holdings. Patient Capital Management, LLC has disclosed CROX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's CROX position evolved
Patient Capital Management, LLC first disclosed a stake in CROX in Q4 2023 at 422,010 shares (US$39.4M). The position peaked in Q2 2026 at 799,426 shares, worth US$96.4M. Across 12 filings, Patient Capital Management, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 730,946 shares valued at US$85.7M — a reduction of -68,480 shares quarter over quarter.. Notable position changes include a 29% increase in Q4 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 422.01K | $39.42M | New |
| Q1 2024 | 419.06K | $60.26M | Reduce |
| Q2 2024 | 379.51K | $55.39M | Reduce |
| Q3 2024 | 380.97K | $55.17M | Hold |
| Q4 2024 | 445.23K | $48.77M | Add |
| Q1 2025 | 511.40K | $54.31M | Add |
| Q2 2025 | 503.38K | $50.98M | Reduce |
| Q3 2025 | 588.79K | $49.19M | Add |
| Q4 2025 | 758.80K | $64.89M | Add |
| Q1 2026 | 842.84K | $69.97M | Add |
| Q2 2026 | 799.43K | $96.44M | Reduce |
| Q3 2026 | 730.95K | $85.75M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CROX and 13F data
CROX (CROCS INC) is a Consumer Discretionary company. 27 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Smead Capital Management, Inc. (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CROX
- Himalaya Capital 887.09K sh · $107.02M · Q2 2026
- No Street GP LP 820.00K sh · $98.92M · Q2 2026
- Smead Capital Management, Inc. 709.82K sh · $83.27M · Q3 2026
- DME Capital Management, LP 669.14K sh · $80.73M · Q2 2026
- WIT Partners Advisory Pte. Ltd. 632.81K sh · $74.24M · Q3 2026
- Evercore Wealth Management, LLC 594.86K sh · $71.76M · Q2 2026
- Punch Card Management L.P. 577.17K sh · $69.63M · Q2 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held CROX?
Patient Capital Management, LLC has disclosed CROX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Patient Capital Management, LLC's current position in CROX?
As of Q3 2026, Patient Capital Management, LLC holds 730.95K shares of CROX (CROCS INC), valued at $85.75M, representing 2.90% of its reported portfolio and ranking #16.
Has Patient Capital Management, LLC been buying or selling CROX?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in CROX. The position peaked in Q2 2026 at 799.43K shares.
Which other funds hold CROX?
Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Smead Capital Management, Inc., among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.